Award details

Technical development of a novel vaccine vehicle for cattle pathogens

ReferenceBB/L02442X/1
Principal Investigator / Supervisor Professor Keith Matthews
Co-Investigators /
Co-Supervisors
Institution University of Edinburgh
DepartmentSch of Biological Sciences
Funding typeResearch
Value (£) 305,156
StatusCompleted
TypeResearch Grant
Start date 27/10/2014
End date 21/04/2017
Duration30 months

Abstract

unavailable

Summary

Trypanosoma theileri is a ubiquitous single celled organism present in cattle herds worldwide. Using knowledge of gene expression and protein trafficking in other trypanosomatid organisms, we have successfully developed T. theileri as a delivery system for vaccine antigens and therapeutics. Following recommendations from several Animal Health companies, we now aim to develop and demonstrate the potential of T. theileri as an effective and practical vaccine-vehicle, providing a clear route to commercialisation. In a two-step development path, Phase 1 will focus on technical refinements and analysis of the viability of the vaccine-vehicle during storage and distribution. The flexibility of the system to express antigens from a range of pathogens will also be established. Phase 2 will entail confirmation of the in vivo efficacy of the refinements developed in Phase 1. Combined the experiments will address key hurdles to the commercial development of this patented vaccine system.
Committee Not funded via Committee
Research TopicsAnimal Health, Immunology, Microbiology
Research PriorityX – Research Priority information not available
Research Initiative Follow-On Fund Super (SuperFOF) [2012-2015]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file